drugset / Trial / NCT03784495

Melatonin Plus Aminoacids for Sarcopenic Elderly

NCT03784495

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the effectiveness of melatonin and essential aminoacid supplementation on body composition, protein metabolism, strength and inflammation. The investigators performed a Randomized controlled parallel groups preliminary trial in 159 elderly sarcopenic people (42/117 men/women) assigned to 4 groups: isocaloric placebo (P, n=44), melatonin (M, 1 mg/daily, n=42,), essential aminoacids (eAA 4 g/daily, n=40) or eAA plus melatonin (eAAM, 4 g eAA and 1 mg melatonin/daily, n= 30). The period of intervention was 4 weeks. Data from body composition (DXA), strength (handgrip test) and biochemical parameters for the assessment of protein metabolism (albumin) and inflammation (PRC) were collected at baseline and after the 4-week intervention

Timeline

Start
2014-01-01
Primary completion
2014-12-31
Completion
2015-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Essential Aminoacids Unknown 4 g
Subject Melatonin Small molecule 1 mg

Indications